
Researchers synthesized gold nanoparticles to target the tight junction specifically and demonstrated that transcranial picosecond laser stimulation of the nanoparticles post-intravenous injection increases the permeability of the blood-brain barrier.
(Illustration credit: Nano Letters)
A University of Texas at Dallas-led team of researchers has developed a new technique to open the blood-brain barrier temporarily to deliver medication to the brain.
Getting medication past the brain’s unique and protective blood vessels, known as the blood-brain barrier, is one of the biggest challenges in treating brain and central nervous system diseases, said Dr. Zhenpeng Qin, associate professor of mechanical engineering at UT Dallas and co-corresponding author of the study that describes the method. The technique uses light and nanoparticles to pry open temporarily these barriers — called tight junctions — to allow medication to reach its target.
Qin and his colleagues in the Erik Jonsson School of Engineering and Computer Science and at other institutions demonstrated the approach in mice in a study published online Sept. 13 in the journal Nano Letters.
The findings are the result of five years of research funded in part by the Cancer Prevention and Research Institute of Texas (CPRIT). Qin said the approach could lead to treatments for brain tumors and Lou Gehrig’s disease, also known as amyotrophic lateral sclerosis; aid in stroke recovery; and deliver gene therapy. Qin said further development and testing is needed before it could be used in humans.
“Approaches to increase blood-brain barrier [BBB] permeability are essential to advance therapeutics for central nervous system diseases,” said Xiaoqing Li, the paper’s co-lead author and a biomedical engineering doctoral student at UT Dallas.
The technique involves injecting gold nanoparticles, which absorb light, into the bloodstream to target the blood-brain barrier. Researchers apply picosecond (one-trillionth of a second) laser pulses externally to activate the gold nanoparticles.
“The action produces a tiny mechanical force that temporarily breaks the barrier open so a drug can enter the blood flow into the brain,” Li said.
The study demonstrated that the technique did not damage the blood-brain barrier or the constriction and dilation of blood vessels, called vasomotion.
“We demonstrated that the BBB permeability can be modulated without significant disruption to the spontaneous vasomotion or the structure of the neurovascular unit,” said Dr. Qi Cai, mechanical engineering research associate and co-lead author of the paper.
In their experiments, the researchers tested the method with cargos of antibodies, liposomes and adeno-associated viral vectors, which can be used to carry gene-editing components.
In August, Qin received a fourth CPRIT grant to study whether the method can be used to treat glioblastoma, the most common malignant brain tumor in adults. He and his team aim to design and produce magnetic nanoparticles that can be stimulated to disrupt the blood-brain barrier using magnetic fields.
“Support from CPRIT has been instrumental in our work,” said Qin, who received grants from the state agency — the second-largest cancer research and prevention program in the world — in 2016, 2018 and 2019. “When we started, we had an idea, basically to use nanoparticles to target specific components of the blood-brain barrier with minimal injury.”
The Nano Letters study involved a global interdisciplinary team of researchers including Dr. Heather Hayenga and Dr. Shashank Sirsi, both assistant professors of bioengineering at UT Dallas. Additional UT Dallas co-authors included Dr. Hejian Xiong, research scientist in mechanical engineering; Peiyuan Kang PhD’20, now a postdoctoral researcher at Harvard Medical School; and Dr. Xiuying Li, now a scientist at Nexus Pharmaceuticals Inc.
Other collaborators included researchers at UT Southwestern Medical Center: co-corresponding author Dr. Robert Bachoo, associate professor of neurology and internal medicine; Dr. Vamsidhara Vemireddy, co-lead author; and Dr. Edward Pan, associate professor of neurology and neurological surgery and section head of neuro-oncology.
Original Article: Team Engineers New Way To Get Medication Past Blood-Brain Barrier
More from: University of Texas at Dallas | University of Texas Southwestern Medical Center | Trinity College Dublin |
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Blood-brain barrier
- Indo-American scientists develop algorithm for early detection of Brain Blood Barrier
HYDERABAD: Two Indo-American Scientists, Venkata Ravi Kiran Kolla, a senior software engineer and senior research scientist, along with Niharika Reddy Meenigea, researcher and a senior data analyst, ...
- The impact of common viral infections on blood-brain barrier function and insulin sensitivity
A new study discusses the impact of several human viruses on blood-brain barrier function and insulin sensitivity.
- A TREM2 activating antibody with a transport vehicle that could boost the metabolism and function of brain microglia
The protein TREM2, which in humans is encoded by the TREM2 gene, is known to play a crucial role in the growth and development of different types of immune cells, including microglia. Microglia are ...
- Disruption of the blood-brain barrier due to long COVID
In a recent study posted to the Research Square* preprint server, researchers explored the destruction of the blood-brain barrier (BBB) due to cognitive impairment associated with long coronavirus ...
- Sunnybrook researchers safely breach the blood-brain barrier in large and critical brain structures in Alzheimer’s disease
Sunnybrook researchers continue their leading-edge work in focused ultrasound and Alzheimer’s disease (AD) as recent findings demonstrate the safety of using image-guided focused ultrasound to ...
Go deeper with Google Headlines on:
Blood-brain barrier
[google_news title=”” keyword=”blood-brain barrier” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Blood-brain barrier permeability
- The impact of common viral infections on blood-brain barrier function and insulin sensitivity
A new study discusses the impact of several human viruses on blood-brain barrier function and insulin sensitivity.
- China NMPA accepts Alpha Biopharma's NDA for Zorifertinib to treat EGFR-mutated NSCLC patients with CNS metastases
China NMPA accepts Alpha Biopharma's NDA for Zorifertinib to treat EGFR-mutated NSCLC patients with CNS metastases: Shanghai Tuesday, January 31, 2023, 13:00 Hrs [IST] Alpha Bioph ...
- Alpha Biopharma Submits New Drug Application for Zorifertinib, a Next-Generation EGFR-TKI to Treat EGFR-mutated NSCLC Patients with CNS Metastases
Alpha Biopharma, a developer of innovative drugs, announces that the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) has accepted its New Drug Application (NDA) ...
- Disruption of the blood-brain barrier due to long COVID
In a recent study posted to the Research Square* preprint server, researchers explored the destruction of the blood-brain barrier (BBB ... remarkably elevated BBB permeability within the brain ...
- Clinical trial delivers chemotherapy to pediatric brain tumours using MRI-guided focused ultrasound
A brain scan shows an MRI-guided focused ultrasound opening the blood-brain barrier for delivery of chemotherapy to a common brain tumour in children (photo courtesy of Sunnybrook) A team of Toronto ...
Go deeper with Google Headlines on:
Blood-brain barrier permeability
[google_news title=”” keyword=”blood-brain barrier permeability” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]